{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T01:35:17Z","timestamp":1768181717223,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Animal models are essential for testing new pressurized intraperitoneal aerosol chemotherapy (PIPAC) protocols; however, no immunocompetent animal model of peritoneal surface malignancies (PSMs) treated with PIPAC has been established. This study evaluated the feasibility, safety, and oncological efficacy of PIPAC in a rabbit PSM model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study was conducted in two phases: (1) Feasibility Assessment: Three healthy rabbits underwent three consecutive PIPAC procedures (saline) at weekly intervals. The rabbits\u2019 well-being, morbidity, mortality, and histological changes were monitored. (2) Treatment Phase: Rabbits with PSM were treated with PIPAC using oxaliplatin, cisplatin-doxorubicin, or saline. Parameters such as animal well-being, ascites volume, morbidity, Peritoneal Cancer Index (PCI), histological response (Peritoneal Regression Grading Score [PRGS]), tumor cell proliferation\/apoptosis, and circulating tumor DNA (ctDNA) levels were assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>PIPAC was feasible and safe, with no increased morbidity or mortality. PIPAC demonstrated antitumor efficacy with lower PCI (control 21.6 vs. oxaliplatin 9.2 vs. cisplatin-doxorubicin 10.2; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001), improved histological response (PRGS: control 3.38 vs. oxaliplatin 1.95 vs. cisplatin-doxorubicin 1.85; <jats:italic>p<\/jats:italic>\u00a0=\u00a00.01), and reduced tumor cell proliferation (control 5.3% vs. oxaliplatin 0.82% vs. cisplatin-doxorubicin 0.62%; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.0001). ctDNA levels showed promise for monitoring treatment response, warranting further investigation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study confirms the feasibility and effectiveness of PIPAC with oxaliplatin or cisplatin-doxorubicin in rabbits with PSM. The model provides a foundation for future research on PIPAC protocols and related treatments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17251-7","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:23:30Z","timestamp":1745580210000},"page":"6050-6057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Feasibility of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in a Rabbit Model of Peritoneal Metastases: PIPALIM Project"],"prefix":"10.1245","volume":"32","author":[{"given":"Sylvia M.","family":"Bardet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Yardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Chaunavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaelle","family":"Maillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymeric","family":"Rouchaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvaine","family":"Durand Fontanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-6474","authenticated-orcid":false,"given":"Abdelkader","family":"Taibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"4","key":"17251_CR1","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/cancers15041125","volume":"15","author":"A Di Giorgio","year":"2023","unstructured":"Di Giorgio A, Macr\u00ec A, Ferracci F, Robella M, Visaloco M, De Manzoni G, et al. 10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis. Cancers (Basel). 2023;15(4):1125.","journal-title":"Cancers (Basel)."},{"issue":"7","key":"17251_CR2","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1245\/s10434-020-09332-6","volume":"28","author":"A Taibi","year":"2021","unstructured":"Taibi A, Teixeira Farinha H, Durand Fontanier S, Sayedalamin Z, H\u00fcbner M, Sgarbura O. Pressurized intraperitoneal aerosol chemotherapy enhanced by electrostatic precipitation (ePIPAC) for patients with peritoneal metastases. Ann Surg Oncol. 2021;28(7):3852\u201360.","journal-title":"Ann Surg Oncol."},{"issue":"Suppl 1","key":"17251_CR3","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.21037\/jgo-20-257","volume":"12","author":"RJ Lurvink","year":"2021","unstructured":"Lurvink RJ, Rovers KP, Nienhuijs SW, Creemers GJ, Burger JWA, de Hingh IHJ. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review. J Gastrointest Oncol. 2021;12(Suppl 1):S242\u201358.","journal-title":"J Gastrointest Oncol."},{"issue":"12","key":"17251_CR4","doi-asserted-by":"publisher","first-page":"107250","DOI":"10.1016\/j.ejso.2023.107250","volume":"49","author":"C Taliento","year":"2023","unstructured":"Taliento C, Restaino S, Scutiero G, Arcieri M, Bernardi G, Martinello R, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in patients with ovarian cancer: a systematic review. Eur J Surg Oncol. 2023;49(12):107250.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"17251_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/pp-2022-0102","volume":"7","author":"O Sgarbura","year":"2022","unstructured":"Sgarbura O, Eveno C, Alyami M, Bakrin N, Guiral DC, Ceelen W, et al. Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC). Pleura Peritoneum. 2022;7(1):1\u20137.","journal-title":"Pleura Peritoneum."},{"issue":"26","key":"17251_CR6","first-page":"29024","volume":"12","author":"M Shariati","year":"2020","unstructured":"Shariati M, Lollo G, Matha K, Descamps B, Vanhove C, Van de Sande L, et al. Synergy between Intraperitoneal Aerosolization (PIPAC) and cancer nanomedicine: cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian cancer. ACS Appl Mater Interfaces. 2020;12(26):29024\u201336.","journal-title":"ACS Appl Mater Interfaces."},{"issue":"5","key":"17251_CR7","doi-asserted-by":"publisher","first-page":"e0300241","DOI":"10.1371\/journal.pone.0300241","volume":"19","author":"D G\u00f6hler","year":"2024","unstructured":"G\u00f6hler D, Oelschl\u00e4gel K, Ouaissi M, Giger-Pabst U. Performance of different nebulizers in clinical use for pressurized intraperitoneal aerosol chemotherapy (PIPAC). PLoS One. 2024;19(5):e0300241.","journal-title":"PLoS One."},{"issue":"1","key":"17251_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jviscsurg.2022.10.001","volume":"160","author":"M Pocard","year":"2023","unstructured":"Pocard M, So JBY, Huchon C, Robella M, Chavatte-Palmer P, Eveno C, et al. PIPAC nebulizer: How to test the new devices in the market, expert recommendations. J Visc Surg. 2023;160(1):52\u20134.","journal-title":"J Visc Surg."},{"issue":"1","key":"17251_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1515\/pp-2016-0006","volume":"1","author":"F Gremonprez","year":"2016","unstructured":"Gremonprez F, Willaert W, Ceelen W. Animal models of colorectal peritoneal metastasis. Pleura Peritoneum. 2016;1(1):23\u201343.","journal-title":"Pleura Peritoneum."},{"key":"17251_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2407-10-124","volume":"10","author":"LJ Mei","year":"2010","unstructured":"Mei LJ, Yang XJ, Tang L, Hassan AHAS, Yonemura Y, Li Y. Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer. BMC Cancer. 2010;10:124.","journal-title":"BMC Cancer."},{"issue":"5","key":"17251_CR11","doi-asserted-by":"publisher","first-page":"e0177212","DOI":"10.1371\/journal.pone.0177212","volume":"12","author":"V Prieto","year":"2017","unstructured":"Prieto V, Ludwig JM, Farris AB, Nagaraju GP, Lawal TO, El-Rayes B, et al. Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study. PLoS One. 2017;12(5):e0177212.","journal-title":"PLoS One."},{"issue":"7","key":"17251_CR12","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie Du Sert","year":"2020","unstructured":"Percie Du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Boutron, I \u00e9diteur. PLoS Biol. 2020;18(7):e3000410.","journal-title":"PLoS Biol."},{"issue":"8","key":"17251_CR13","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1245\/s10434-022-11577-2","volume":"29","author":"A Taibi","year":"2022","unstructured":"Taibi A, Sgarbura O, H\u00fcbner M, Bardet SM, Alyami M, Bakrin N, et al. Feasibility and safety of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy with or without intraoperative intravenous 5-fluorouracil and leucovorin for colorectal peritoneal metastases: a multicenter comparative cohort study. Ann Surg Oncol. 2022;29(8):5243\u201351.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"17251_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neurad.2020.03.005","volume":"48","author":"SM Bardet","year":"2021","unstructured":"Bardet SM, Cortese J, Blanc R, Mounayer C, Rouchaud A. Multiphoton microscopy for pre-clinical evaluation of flow-diverter stents for treating aneurysms. J Neuroradiol. 2021;48(3):200\u20136.","journal-title":"J Neuroradiol."},{"issue":"5","key":"17251_CR15","doi-asserted-by":"publisher","first-page":"101042831769838","DOI":"10.1177\/1010428317698381","volume":"39","author":"F Pascale","year":"2017","unstructured":"Pascale F, Fazel A, Namur J, Ghegediban SH, D\u2019Inca H, Wassef M, et al. Laparoscopic subperitoneal injection of chemo-loaded particles lowers tumor growth on a rabbit model of peritoneal carcinomatosis. Tumour Biol. 2017;39(5):101042831769838.","journal-title":"Tumour Biol."},{"issue":"1","key":"17251_CR16","doi-asserted-by":"publisher","first-page":"16723","DOI":"10.1038\/s41598-017-17079-6","volume":"7","author":"N Muhanna","year":"2017","unstructured":"Muhanna N, Di Grappa MA, Chan HHL, Khan T, Jin CS, Zheng Y, et al. Cell-Free DNA kinetics in a pre-clinical model of head and neck cancer. Sci Rep. 2017;7(1):16723.","journal-title":"Sci Rep."},{"issue":"3","key":"17251_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ejso.2022.11.097","volume":"49","author":"ML Perrin","year":"2023","unstructured":"Perrin ML, Bardet SM, Yardin C, Durand Fontanier S, Taibi A. Effect of 5-fluoro-uracile + oxaliplatin chemotherapy on the histological response of peritoneal and hepatic corectal metastases in a mouse model: PEPITO experimental study. Eur J Surg Oncol. 2023;49(3):619\u201325.","journal-title":"Eur J Surg Oncol."},{"issue":"7","key":"17251_CR18","doi-asserted-by":"publisher","first-page":"e0220360","DOI":"10.1371\/journal.pone.0220360","volume":"14","author":"A Taibi","year":"2019","unstructured":"Taibi A, Albouys J, Jacques J, Perrin ML, Yardin C, Durand Fontanier S, et al. Comparison of implantation sites for the development of peritoneal metastasis in a colorectal cancer mouse model using non-invasive bioluminescence imaging. PLoS One. 2019;14(7):e0220360.","journal-title":"PLoS One."},{"issue":"1","key":"17251_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12885-019-5658-5","volume":"19","author":"L Van de Sande","year":"2019","unstructured":"Van de Sande L, Willaert W, Cosyns S, De Clercq K, Shariati M, Remaut K, et al. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC). BMC Cancer. 2019;19(1):424.","journal-title":"BMC Cancer."},{"issue":"7","key":"17251_CR20","first-page":"586","volume":"21","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Wei T, Ma R, Fu Y, Yang R, Su Y, et al. Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei. Cancer Biol Med. 2024;21(7):586\u2013605.","journal-title":"Cancer Biol Med."},{"issue":"3","key":"17251_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41416-024-02717-4","volume":"131","author":"C Ramos","year":"2024","unstructured":"Ramos C, Gerakopoulos V, Oehler R. Metastasis-associated fibroblasts in peritoneal surface malignancies. Br J Cancer. 2024;131(3):407\u201319.","journal-title":"Br J Cancer."},{"issue":"7","key":"17251_CR22","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1053\/j.gastro.2024.08.007","volume":"167","author":"JJ Zhao","year":"2024","unstructured":"Zhao JJ, Ong CAJ, Srivastava S, Chia DKA, Ma H, Huang K, et al. Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases. Gastroenterology. 2024;167(7):1384-1398.e4.","journal-title":"Gastroenterology."},{"issue":"1","key":"17251_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12885-021-07955-w","volume":"21","author":"M Mimouni","year":"2021","unstructured":"Mimouni M, Richard C, Adenot P, Letheule M, Tarrade A, Sandra O, et al. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model. BMC Cancer. 2021;21(1):461. https:\/\/doi.org\/10.1186\/s12885-021-07955-w.","journal-title":"BMC Cancer."},{"key":"17251_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006447","author":"R Orgad","year":"2024","unstructured":"Orgad R, Bakrin N, Bonnefoy I, Villeneuve L, Alyami M, Alhadeedi O, et al. Number of pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatments is associated with longer survival: analysis of a large prospective cohort of patients with unresectable peritoneal surface malignancies. Ann Surg. 2024. https:\/\/doi.org\/10.1097\/SLA.0000000000006447.","journal-title":"Ann Surg."},{"issue":"10","key":"17251_CR25","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3390\/cancers14102557","volume":"14","author":"A Balmer","year":"2022","unstructured":"Balmer A, Clerc D, Toussaint L, Sgarbura O, Ta\u00efbi A, H\u00fcbner M, et al. Selection criteria for pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment in patients with peritoneal metastases. Cancers (Basel). 2022;14(10):2557.","journal-title":"Cancers (Basel)."},{"issue":"6","key":"17251_CR26","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/XCS.0000000000001028","volume":"238","author":"VV Bansal","year":"2024","unstructured":"Bansal VV, Belmont E, Godley F, Dhiman A, Witmer HD, Li S, et al. Utility of circulating tumor DNA assessment in characterizing recurrence sites after optimal resection for metastatic colorectal cancer. J Am Coll Surg. 2024;238(6):1013\u201320.","journal-title":"J Am Coll Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17251-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:57:33Z","timestamp":1751464653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["17251"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17251-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}